Loading clinical trials...
Loading clinical trials...
A Phase I, Subject and Investigator Blind Randomized, Study to Investigate the Pharmacokinetics, Safety and Tolerability of Retosiban in Healthy Japanese Women
Conditions
Interventions
Retosiban solution for Infusion
Placebo
Locations
1
United States
GSK Investigational Site
Glendale, California, United States
Start Date
March 2, 2015
Primary Completion Date
April 17, 2015
Completion Date
April 17, 2015
Last Updated
May 9, 2017
NCT02377466
NCT02292784
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions